Dan Avi Landau BSc, MD, PhD

Dan Landau, MD, Ph.D., is a physician-scientist who has pioneered the study of cancer evolution as a central obstacle on the path to curative therapy. His work has delineated the evolutionary course that allows cancer cells to rescind the multicellular contract, diversify and become resistant to therapy. Dr. Landau completed undergraduate and medical school degrees at Tel Aviv University, and Ph.D. training at Paris Diderot University. His post-graduate training included internal medicine, hematology and medical oncology training at Yale University. He also completed a post-doctoral research fellowship at the Dana Farber Cancer Institute and the Broad Institute of Harvard and MIT. In 2016, he was jointly appointed as an assistant professor of medicine and a member of the Institute of Computational Biomedicine at Weill Cornell Medicine, as well as a core member of the New York Genome Center. He cares for bone marrow transplant patients at the New York Presbyterian hospital. His work was recognized with awards from Burroughs Wellcome Fund, NIH Big Data to Knowledge initiative, Stand Up to Cancer, Leukemia & Lymphoma Society, American Society of Clinical Investigation, Sydney Kimmel Foundation, and American Society of Hematology.